ExpreS2ion Biotech Holding AB Logo

ExpreS2ion Biotech Holding AB

EXPRS2 | ST

Overview

Corporate Details

ISIN(s):
SE0008348262 (+4 more)
LEI:
549300FJK50P1ORYJC45
Country:
Sweden
Address:
C/O Mindpark, 252 25 Helsingborg
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

ExpreS2ion Biotech Holding AB is a clinical-stage biotechnology company that develops novel vaccines and immunotherapies for major global health challenges. The company utilizes its proprietary ExpreS2™ protein expression platform to advance a focused portfolio of candidates targeting infectious diseases and cancer. Key development programs include therapeutic cancer vaccines, such as a candidate for HER2-expressing breast cancer, and prophylactic vaccines for diseases like malaria. Through its advanced platform technology and strategic partnerships, the company aims to transform healthcare by developing innovative, life-saving treatments.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for ExpreS2ion Biotech Holding AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ExpreS2ion Biotech Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ExpreS2ion Biotech Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
VERICI DX PLC Logo
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
United Kingdom VRCI
Vicore Pharma Holding Logo
Develops AT2 receptor drugs and a digital therapeutic for pulmonary fibrosis.
Sweden VICO
Vivoryon Therapeutics N.V. Logo
Develops small molecule therapies for severe age-related, inflammatory, and neurodegenerative diseases.
Germany VVY
R&D in renewable energy & manufacturing specialized tools for automotive & engineering.
Slovakia N/A
Xintela AB Logo
Develops stem cell therapies and targeted antibody treatments for cancer and osteoarthritis.
Sweden XINT
Xlife Sciences AG Logo
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland XLS
XTL Biopharmaceuticals Ltd. Logo
Acquires and develops late-stage therapeutics for autoimmune diseases.
Israel XTLB
Yoshi Innovation Spolka Akcyjna Logo
A tech fund incubating MedTech, biotech, and defense ventures with investment and IP protection.
Poland YOS
Zealand Pharma Logo
Develops innovative peptide medicines for metabolic and rare diseases.
Denmark ZEAL
Ziccum AB Logo
Licenses drying tech for thermostable vaccines & biologics, eliminating the cold chain.
Sweden ZICC